Cataract

Posted on April 27, 2015June 9, 2016 by admin

Cataract is a very common eye problem in both men and women, and it is thought that about a third of people in the UK over the age of

Macular Degeneration

Posted on April 27, 2015June 9, 2016 by admin

Macular Degeneration (AMD) or age related macular degeneration is a serious eye problem that can cause irreversible

Diabetic Retinopathy

Posted on April 27, 2015June 9, 2016 by admin

Diabetes can start at any age but the western lifestyle and diet puts many people at risk of developing this disease

Retinal Vein Occlusion

Posted on April 27, 2015June 9, 2016 by admin

Retinal vein occlusion is second only to diabetic retinopathy as the most common retinal vascular condition

CONTACT US

Posted on April 28, 2015June 9, 2016 by admin

Click here to contact us and find the clinics.

EYE PROBLEM NEWS

Treat diabetic macular oedema with one eye injection in three years?

It may sound too good to be true but a new injectable steroid product is now on the market in the UK and comes with the claim that only one injection is required which can last three years. This product called Iluvien (drug name fluocinolone) is new slow release implant product licensed to treat diabetic macular oedema.

...

Eylea – finally a serious competitor Lucentis?

Eylea (also known as aflibercept and VEGF Trap Eye) has now been approved and licensed in Europe. It’s UK launch is planned for the begninning of december 2012. With great success so far on the American market the manufacturer (Regeneron) and distributor (Bayer) are hopeful that it will make an impact on treatment of wet AMD in the UK.

...

Cataract Surgery. Will the NHS or my insurance company pay?

Recently cataract surgery has been restricted by some primary care trusts in Manchester and Cheshire. The aim is to restrict surgery to patients who really need the operation but the thresholds, sometimes just based on vision chart measurements not quality of life have been set at a level which in some cases is a worse level of vision than would be necessary

...

Lucentis price cut in the UK

The biggest controversy in relation to treatment with lucentis has been the price. The need for repeated monthly review and repeat treatments soon cause the overall cost to build up. Understandably, the manufacturer needs to recoup the costs of such a ground breaking development and invest in future research.

...